![](/img/cover-not-exists.png)
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
John Murren, Manuel Modiano, Shivaani Kummar, Caroline Clairmont, Merrill Egorin, Edward Chu, Mario SznolVolume:
23
Language:
english
Pages:
13
DOI:
10.1007/s10637-005-5857-6
Date:
January, 2005
File:
PDF, 273 KB
english, 2005